Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DURECT Corporation - Common Stock (NQ:DRRX)

0.8490 +0.0490 (+6.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,432
Open 0.8000
Bid (Size) 0.8005 (13)
Ask (Size) 0.8500 (20)
Prev. Close 0.8000
Today's Range 0.7973 - 0.8519
52wk Range 0.7010 - 1.880
Shares Outstanding 24,489,843
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DRRX Stock Earnings: Durect Beats EPS, Beats Revenue for Q4 2023
DRRX stock results show that Durect beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga

Performance

YTD
+7.4%
+7.4%
1 Month
+5.3%
+5.3%
3 Month
-10.6%
-10.6%
6 Month
-36.6%
-36.6%
1 Year
-32.1%
-32.1%

More News

Read More
Top 3 Health Care Stocks That Are Preparing To Pump This Month
Via Benzinga
Recap: Durect Q3 Earnings
Via Benzinga
Durect Earnings Preview
Via Benzinga
Why Is Pain & Liver Disease Focused DURECT Stock Plunging Today?
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
An Overview of Durect's Earnings
Via Benzinga
Earnings Preview: Durect
Via Benzinga
DRRX Stock Earnings: Durect Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
DRRX Stock Earnings: Durect Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Durect: Q4 Earnings Insights
Via Benzinga
Durect's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Crude Oil Falls 2.5%; Ralph Lauren Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Dow Falls Over 100 Points; US Wholesale Inventories Edge Higher
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Earnings Scheduled For November 13, 2023
Via Benzinga
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
US Stocks Higher; Kellanova Sales Top Estimates
Via Benzinga
Topics Stocks
Exposures US Equities
Cantor Fitzgerald Is Souring on Lucid Motors (LCID) Stock
Via InvestorPlace
Why Is Sleep Number (SNBR) Stock Down 40% Today?
Via InvestorPlace

Frequently Asked Questions

Is DURECT Corporation - Common Stock publicly traded?
Yes, DURECT Corporation - Common Stock is publicly traded.
What exchange does DURECT Corporation - Common Stock trade on?
DURECT Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DURECT Corporation - Common Stock?
The ticker symbol for DURECT Corporation - Common Stock is DRRX on the Nasdaq Stock Market
What is the current price of DURECT Corporation - Common Stock?
The current price of DURECT Corporation - Common Stock is 0.8490
When was DURECT Corporation - Common Stock last traded?
The last trade of DURECT Corporation - Common Stock was at 03/21/25 04:00 PM ET
What is the market capitalization of DURECT Corporation - Common Stock?
The market capitalization of DURECT Corporation - Common Stock is 20.79M
How many shares of DURECT Corporation - Common Stock are outstanding?
DURECT Corporation - Common Stock has 21M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.